Recombinant DNA Technology Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

Recombinant-DNA-Technology-Market

Recombinant DNA technology (rDNA) helps to identify the gene function and its regulation in normal and pathogenic condition. Recombinant DNA is created artificially from two or more DNA molecules, which are incorporated into a single molecule. Recombinant DNA technology examines the functioning of the living system by manipulating their genome for production of useful metabolites. Recombinant DNA technology has introduced new classes of organism namely genetically modified organism (GMO) or living modified organism (LMO).  It can develop genetically modified crops (BT cotton), cloned animals, bio pesticides, biofuel, bioremediation, and gene therapy successfully. Impact of rDNA on human and environment in the context of safety is assessed by researchers.

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/893

Advance rDNA technology have resulted in production of various therapeutic proteins, such as insulin, hormones, edible vaccines, interleukins, and monoclonal antibodies. It has enormous potential to revolutionize the medical and clinical medicines. rDNA technology has triggered the biopharmaceutical industries towards the development of various rDNA product, in turn favoring the growth of recombinant DNA technology market.

Global recombinant DNA technology market – trends and opportunity

At Jef Boeke’s lab, 2017, scientists are rewriting the yeast genome, which aims to create custom-made chunks of DNA codes, which can be inserted into the cells to alter their functions and improve drug development. Researchers intend to construct whole new organisms with functional genes, which will help to develop vaccines, proteins, drugs, and biofuels.

According to Applied Science Report, 2013, integrating biotechnology and genomics in the drug development process gives the opportunity to companies to save up to US$ 300 million per drug, which is about one-third of the cost of the drug. This prospect is bringing drug two year earlier in the market, indicating the significance of recombinant drugs and the need for manufacturing.

Increasing investments in research and development pool to favor the growth of recombinant DNA technology

Increasing government funding in the U.S. by the Department of Health And Human Services (HHS) to National Institute of Health’s research and development for various disciplinary field gene therapy applications is the major driving factor for the growth of recombinant DNA technology market. Effect of various factors, such as food, health problems, and environmental issues on growing population is another driving factor for the growth of recombinant DNA technology market. Diseases such as cancers, genetic disorder, plant and animal disorders, and development of anti-fungal or anti-viral abilities of plants have high demand in therapeutic approaches, which will favor the growth of recombinant DNA technology market.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/893

Lack of government funding for research and development in emerging economies is the major restraint for the growth of recombinant DNA technology market.

The major key players operating the recombinant DNA technology market include Horizon Discovery Group PLC, F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Cibus; Monsanto Company, Amgen Inc., New England Biolabs, Novartis AG, GenScript, GlaxoSmithKline plc, Pfizer Inc., Novo Nordisk, and Eli Lilly and Company.

You may be interested

Closed MRI Systems Market – Latest Advancements & Market Outlook 2018 to 2026
Healthcare
Healthcare

Closed MRI Systems Market – Latest Advancements & Market Outlook 2018 to 2026

Pareesh Phulkar - May 21, 2018

Magnetic resonance imaging (MRI) is a non-invasive medical test that uses powerful magnetic field, radio waves, and a computer to produce detailed virtual image of internal organs…

Rising number of surgical procedures coupled with increasing trauma cases to foster global hemostasis & tissue sealing agents market
Healthcare
Healthcare

Rising number of surgical procedures coupled with increasing trauma cases to foster global hemostasis & tissue sealing agents market

Albert R - May 19, 2018

Hemostasis is a physiological processes, which maintains fluidity of blood by preventing blood loss from body. Hemostasis is characterized by clot formation by activating the natural coagulation…

Synovial Sarcoma Treatment Market Regional Insights
Healthcare
Healthcare

Synovial Sarcoma Treatment Market Regional Insights

Albert R - May 19, 2018

Synovial sarcoma consists of abnormal growth of soft-tissue. Synovial sarcoma is a rare type of cancer and is more prevalent in teenagers and young adults. Synovial sarcoma…

Most from this category